Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, M.
Right arrow Articles by Miller, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, M.
Right arrow Articles by Miller, L. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 8, 4778-4785, February 19, 1999

Structurally Related Peptide Agonist, Partial Agonist, and Antagonist Occupy a Similar Binding Pocket within the Cholecystokinin Receptor
RAPID ANALYSIS USING FLUORESCENT PHOTOAFFINITY LABELING PROBES AND CAPILLARY ELECTROPHORESIS

Maoqing DongDagger , Xi-Qin DingDagger , Delia I. PinonDagger , Elizabeth M. HadacDagger , Robert P. Oda§, James P. Landers, and Laurence J. MillerDagger

From the Dagger  Center for Basic Research in Digestive Diseases, § Protein Core Facility, Mayo Clinic, Rochester, Minnesota 55905, and  Analytical Division, Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260

The molecular basis of ligand binding to receptors provides important insights for drug development. Here, we explore domains of the cholecystokinin (CCK) receptor that are critical for ligand binding, using a novel series of fluorescent photolabile probes, receptor proteolysis, and rapid high resolution separation of peptide fragments by capillary electrophoresis. Each probe incorporated the same fluorophore and a photolabile p-benzoylphenylalanine at the amino terminus of the pharmacophoric domain (residue 24 of CCK-33) of CCK analogues representing full agonist, partial agonist, and antagonist of this receptor. Each was used to label the CCK receptor expressed on Chinese hamster ovary-CCKR cells, with the labeled domain then released by cyanogen bromide cleavage. Capillary electrophoresis with laser-induced fluorescence detection achieved an on-capillary mass sensitivity of 1.6 attomoles (10-18 mol), with an excellent signal-to-noise ratio. Each of the biologically divergent, but structurally similar probes saturably and specifically labeled the same receptor domain, consistent with conservation of "docking" determinants. This had an apparent mass of 2.9 kDa, most consistent with the first extracellular loop domain. An additional probe having its site of covalent attachment in a different region of the probe (residue 29 of CCK-33) labeled a distinct receptor fragment with differential migration on capillary electrophoresis (third extracellular loop). Identification of the specific receptor residue(s) covalently linked to the amino-terminal probes must await further fragmentation and sequence analysis.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. G. Harikumar, D. I. Pinon, and L. J. Miller
Fluorescent Indicators Distributed throughout the Pharmacophore of Cholecystokinin Provide Insights into Distinct Modes of Binding and Activation of Type A and B Cholecystokinin Receptors
J. Biol. Chem., September 15, 2006; 281(37): 27072 - 27080.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Dong, E. M. Hadac, D. I. Pinon, and L. J. Miller
Differential Spatial Approximation between Cholecystokinin Residue 30 and Receptor Residues in Active and Inactive Conformations
Mol. Pharmacol., June 1, 2005; 67(6): 1892 - 1900.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. G. Harikumar and L. J. Miller
Fluorescence Resonance Energy Transfer Analysis of the Antagonist- and Partial Agonist-occupied States of the Cholecystokinin Receptor
J. Biol. Chem., May 13, 2005; 280(19): 18631 - 18635.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. H. Arlander, M. Dong, X.-Q. Ding, D. I. Pinon, and L. J. Miller
Key Differences in Molecular Complexes of the Cholecystokinin Receptor with Structurally Related Peptide Agonist, Partial Agonist, and Antagonist
Mol. Pharmacol., September 1, 2004; 66(3): 545 - 552.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Zoffmann, A. Chollet, and J.-L. Galzi
Identification of the Extracellular Loop 2 as the Point of Interaction between the N Terminus of the Chemokine MIP-1alpha and Its CCR1 Receptor
Mol. Pharmacol., September 1, 2002; 62(3): 729 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. G. Harikumar, D. I. Pinon, W. S. Wessels, F. G. Prendergast, and L. J. Miller
Environment and Mobility of a Series of Fluorescent Reporters at the Amino Terminus of Structurally Related Peptide Agonists and Antagonists Bound to the Cholecystokinin Receptor
J. Biol. Chem., May 17, 2002; 277(21): 18552 - 18560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Behar, A. Bisello, G. Bitan, M. Rosenblatt, and M. Chorev
Photoaffinity Cross-linking Identifies Differences in the Interactions of an Agonist and an Antagonist with the Parathyroid Hormone/Parathyroid Hormone-related Protein Receptor
J. Biol. Chem., January 7, 2000; 275(1): 9 - 17.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Phalipou, R. Seyer, N. Cotte, C. Breton, C. Barberis, M. Hibert, and B. Mouillac
Docking of Linear Peptide Antagonists into the Human V1a Vasopressin Receptor. IDENTIFICATION OF BINDING DOMAINS BY PHOTOAFFINITY LABELING
J. Biol. Chem., August 13, 1999; 274(33): 23316 - 23327.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-Q. Ding, V. Dolu, E. M. Hadac, E. L. Holicky, D. I. Pinon, T. P. Lybrand, and L. J. Miller
Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe
J. Biol. Chem., February 2, 2001; 276(6): 4236 - 4244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Mouledous, C. M. Topham, H. Mazarguil, and J.-C. Meunier
Direct Identification of a Peptide Binding Region in the Opioid Receptor-like 1 Receptor by Photoaffinity Labeling with [Bpa10,Tyr14]Nociceptin
J. Biol. Chem., September 15, 2000; 275(38): 29268 - 29274.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement